iRhythm Holdings, Inc.

IRTC Medical devices

Develops wearable heart monitors that diagnose cardiac arrhythmias.

Jun 2026Revenue $825M/yrExpenses $850M/yr
Expected break-even Sep 2026
Figures by year

When will iRhythm Holdings be profitable?

Its revenue and expense trends are projected to cross in Sep 2026. In the 12 months to Jun 2026, revenue was $825M and expenses $850M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$747M$805M−$57.4M
Dec 2024$592M$707M−$116M
Dec 2023$493M$618M−$125M
Dec 2022$411M$525M−$114M
Dec 2021$323M$423M−$99.9M
Dec 2020$265M$309M−$43.7M
Dec 2019$215M$269M−$54.8M
Dec 2018$147M$193M−$45.7M
Dec 2017$99.1M$127M−$27.6M
Dec 2016$64.1M$79.7M−$15.6M